A Randomized, Double-blind, Placebo-controlled Study of Effects of Two Fixed-dose Leucine-sildenafil Combinations (NS-0300) or Two Fixed-dose Leucine-sildenafil-metformin Combinations (NS-0200) Versus Placebo on Body Weight in Obesity
Phase of Trial: Phase II
Latest Information Update: 03 Dec 2018
At a glance
- Drugs Leucine/metformin/sildenafil (Primary) ; Leucine/sildenafil (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Sponsors NuSirt Biopharma
- 29 Oct 2018 Status changed from recruiting to completed.
- 31 Aug 2018 Biomarkers information updated
- 21 Mar 2018 Status changed from not yet recruiting to recruiting.